BackStemCell Institute Overview

StemCell Institute Current Assets

Track StemCell Institute's current assets ($5.5B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$5.53B
↑ 13.93% YoYΔ $676.48M vs prior year quarter

Peer trimmed avg / median

Loading

StemCell Institute Current Assets History

Loading

StemCell Institute vs. peers: Current Assets Comparison

Loading

StemCell Institute Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

StemCell Institute (7096.T) FAQ

As of the most recent data (June 2026), 7096.T shows a current assets of $5.5B. That compares with $4.9B in the prior-year period — up 13.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 7096.T's current assets is now $5.5B (was $4.9B) — a 13.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether StemCell Institute is outperforming or lagging.

Tracking 7096.T's current assets over time shows whether StemCell Institute is scaling, shrinking, or reshaping that part of the business. The current reading is $5.5B That compares with $4.9B in the prior-year period — up 13.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has StemCell Institute's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $5.5B) with ownership activity and broader fundamentals.

StemCell Institute's current assets is $5.5B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.